Neuvasq Biotechnologies presented its latest work at EBBM 2026.
Public source
Publisher name
Public post
Great to see our latest work heading to EBBM 2026! 🧠 Proud to see Audrey Progneaux presenting our work, go check out her poster if you are there! 👏
Company
Neuvasq Biotechnologies
Advancing innovative Wnt surrogate antibodies to restore blood-CNS barriers.
- Industry
- Biotechnology
- Location
- Gosselies, BE
- Company size
- 11–50 employees
About Neuvasq Biotechnologies
Neuvasq Biotechnologies is pioneering the development of first-in-class Gpr124- and Reck-targeting Wnt surrogate antibodies, designed to restore the integrity of the blood-retina and blood-brain barriers. This groundbreaking approach holds the potential to transform treatments and improve the lives of patients with vascular retinopathies – diabetic macular edema (DME) and wet age-related macular degeneration (wAMD) – or severe neurological disorders.
See moreLatest activity
Latest activity from Neuvasq Biotechnologies
3 signals
People
Neuvasq Biotechnologies welcomed Oya Yilmaz as a Research Associate to the drug discovery team.
Presence & Recognition
Neuvasq Biotechnologies is attending the European Brain Barriers Meeting 2026 on September 16–18 in Aarhus, Denmark to share insights on restoring neurovascular integrity and presenting its multispecific Gpr124-targeting antibodies.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
MaxWell Biosystems
MaxWell Biosystems is represented at the NeuMoS 2026 conference in Zürich, Switzerland, where three speakers will present work on human-derived models for brain development, disease, and genetic diversity.
Presence & Recognition
Cytosurge
Cytosurge presented a poster on non-destructive, same-cell profiling with FluidFM OMNIUM at the ESCP 2026 event in Vienna.
Presence & Recognition
Inoviv
Inoviv won a place in the Innovation Zone at the ELRIG 2026 Drug Discovery conference
Presence & Recognition
bit.bio
bit.bio is attending the German Stem Cell Network Conference 2026 in Berlin.
Presence & Recognition
NewBiologix